東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Identification, Development, and Eva...

Rosser, Ethan Wan.

Linked to FindBook

Google Book

Amazon

博客來

Identification, Development, and Evaluation of Small-Molecule Modulators of Nucleotide Metabolism.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Identification, Development, and Evaluation of Small-Molecule Modulators of Nucleotide Metabolism./
Author:	Rosser, Ethan Wan.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
Description:	190 p.
Notes:	Source: Dissertations Abstracts International, Volume: 82-01, Section: B.
Contained By:	Dissertations Abstracts International82-01B.
Subject:	Organic chemistry. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28001452
ISBN:	9798641421063

Identification, Development, and Evaluation of Small-Molecule Modulators of Nucleotide Metabolism.
Rosser, Ethan Wan.

Identification, Development, and Evaluation of Small-Molecule Modulators of Nucleotide Metabolism. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 190 p.

Source: Dissertations Abstracts International, Volume: 82-01, Section: B.

Thesis (Ph.D.)--University of California, Los Angeles, 2020.

This item must not be sold to any third party vendors.

This dissertation describes the identification, development, and evaluation of small- molecule modulators of nucleotide metabolism. Nucleotides, well-known for their role as the "backbone" of DNA, are essential for a variety of cell processes including energy transfer, formation of lipid membranes, and DNA and RNA synthesis. Small molecule-mediated inhibition of enzymes involved in nucleotide metabolism has shown promise in various therapeutic settings, and our group has demonstrated that inhibition of deoxycytidine kinase combined with perturbations to other nucleotide-producing enzymes can effectively treat acute lymphoblastic leukemia in mouse models.Chapter One details the development and evaluation of inhibitors of deoxycytidine kinase. Expanding upon a scaffold previously identified by our group, structure-activity-relationship studies were undertaken in pursuit of a clinically-viable inhibitor. With the goal of eliminating the presence of a stereocenter within our lead compound while maintaining low- nanomolar affinity for deoxycytidine kinase, a series of analogs containing a gem-dimethyl moiety was produced. In addition, the preclinical pharmacology of the lead compound, DI-87, was evaluated with the aid of PET imaging.Chapter Two describes the development and application of a cell-based metabolic modifier screening platform that leverages the redundancy in pyrimidine metabolism for the discovery of selective uridine monophosphate biosynthesis modulators. In evaluating a library of protein kinase inhibitors, multiple compounds which possess nucleotide metabolism modifying activity were identified. The JNK inhibitor JNK-IN-8 was found to potently inhibit nucleoside transport and engage ENT1. Additionally, the PDK1 inhibitor OSU-03012 and the RAF inhibitor TAK-632 were shown to inhibit the therapeutically relevant enzyme DHODH, and their affinities were unambiguously confirmed through in vitro assays and co-crystallization with human DHODH.

ISBN: 9798641421063Subjects--Topical Terms:

523952
Organic chemistry.
Subjects--Index Terms:

Deoxycytidine Kinase

Identification, Development, and Evaluation of Small-Molecule Modulators of Nucleotide Metabolism.
LDR:03113nmm a2200337 4500 001 2273215
005 20201105110410.5
008 220629s2020 ||||||||||||||||| ||eng d
020 $a 9798641421063
035 $a (MiAaPQ)AAI28001452
035 $a AAI28001452
040 $a MiAaPQ $c MiAaPQ
100 1 $a Rosser, Ethan Wan. $3 3550644
245 1 0 $a Identification, Development, and Evaluation of Small-Molecule Modulators of Nucleotide Metabolism.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 190 p.
500 $a Source: Dissertations Abstracts International, Volume: 82-01, Section: B.
500 $a Advisor: Radu, Caius G.;Jung, Michael E.
502 $a Thesis (Ph.D.)--University of California, Los Angeles, 2020.
506 $a This item must not be sold to any third party vendors.
520 $a This dissertation describes the identification, development, and evaluation of small- molecule modulators of nucleotide metabolism. Nucleotides, well-known for their role as the "backbone" of DNA, are essential for a variety of cell processes including energy transfer, formation of lipid membranes, and DNA and RNA synthesis. Small molecule-mediated inhibition of enzymes involved in nucleotide metabolism has shown promise in various therapeutic settings, and our group has demonstrated that inhibition of deoxycytidine kinase combined with perturbations to other nucleotide-producing enzymes can effectively treat acute lymphoblastic leukemia in mouse models.Chapter One details the development and evaluation of inhibitors of deoxycytidine kinase. Expanding upon a scaffold previously identified by our group, structure-activity-relationship studies were undertaken in pursuit of a clinically-viable inhibitor. With the goal of eliminating the presence of a stereocenter within our lead compound while maintaining low- nanomolar affinity for deoxycytidine kinase, a series of analogs containing a gem-dimethyl moiety was produced. In addition, the preclinical pharmacology of the lead compound, DI-87, was evaluated with the aid of PET imaging.Chapter Two describes the development and application of a cell-based metabolic modifier screening platform that leverages the redundancy in pyrimidine metabolism for the discovery of selective uridine monophosphate biosynthesis modulators. In evaluating a library of protein kinase inhibitors, multiple compounds which possess nucleotide metabolism modifying activity were identified. The JNK inhibitor JNK-IN-8 was found to potently inhibit nucleoside transport and engage ENT1. Additionally, the PDK1 inhibitor OSU-03012 and the RAF inhibitor TAK-632 were shown to inhibit the therapeutically relevant enzyme DHODH, and their affinities were unambiguously confirmed through in vitro assays and co-crystallization with human DHODH.
590 $a School code: 0031.
650 4 $a Organic chemistry. $3 523952
650 4 $a Molecular biology. $3 517296
653 $a Deoxycytidine Kinase
653 $a Dihydroorotate Dehydrogenase
653 $a ENT1
690 $a 0490
690 $a 0307
710 2 $a University of California, Los Angeles. $b Chemistry 0153. $3 2096181
773 0 $t Dissertations Abstracts International $g 82-01B.
790 $a 0031
791 $a Ph.D.
792 $a 2020
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28001452